Cargando…

Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma

Lung adenocarcinoma (LUAD) is a malignant tumor in the respiratory system. The efficacy of current treatment modalities varies greatly, and individualization is evident. Therefore, finding biomarkers for predicting treatment prognosis and providing reference and guidance for formulating treatment op...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xiang, Xu, Ran, Lu, Tong, Wang, Chenghao, Chang, Xiaoyan, Peng, Bo, Shen, Zhiping, Yao, Lingqi, Wang, Kaiyu, Xu, Chengyu, Shi, Jiaxin, Zhang, Ren, Zhao, Jiaying, Zhang, Linyou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432465/ https://www.ncbi.nlm.nih.gov/pubmed/37587188 http://dx.doi.org/10.1038/s41598-023-40592-w

Ejemplares similares

A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments
por: Wang, Chenghao, et al.
Publicado: (2022)

Identification of immunotherapy biomarkers for improving the clinical outcome of homologous recombination deficiency patients with lung adenocarcinoma
por: Zhou, Xiang, et al.
Publicado: (2023)

Identification of lactate metabolism-related subtypes and development of a lactate-related prognostic indicator of lung adenocarcinoma
por: Chang, Xiaoyan, et al.
Publicado: (2022)

Preoperative computed tomography-based tumoral radiomic features prediction for overall survival in resectable non-small cell lung cancer
por: Peng, Bo, et al.
Publicado: (2023)

Multi-omics analysis to identify lung squamous carcinoma lactate metabolism-related subtypes and establish related index to predict prognosis and guide immunotherapy
por: Wang, Chenghao, et al.
Publicado: (2022)

Identification of ubiquitinated substrate proteins and their gene expression patterns in lung adenocarcinoma
por: Xu, Ran, et al.
Publicado: (2021)

Single-cell data analysis of malignant epithelial cell heterogeneity in lung adenocarcinoma for patient classification and prognosis prediction
por: Ran, Xu, et al.
Publicado: (2023)

Mitochondrial Homeostasis–Related lncRNAs are Potential Biomarkers for Predicting Prognosis and Immune Response in Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2022)

Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
por: Xu, Ran, et al.
Publicado: (2022)

Bioinformatics analysis and single-cell RNA sequencing: elucidating the ubiquitination pathways and key enzymes in lung adenocarcinoma
por: Lu, Tong, et al.
Publicado: (2023)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Identification of tumor antigens and immune subtypes in lung squamous cell carcinoma for mRNA vaccine development
por: Zhao, Jiaying, et al.
Publicado: (2022)

A novel protein ubiquitination-related five-gene signature predicts overall survival in patients with lung adenocarcinoma
por: Xu, Ran, et al.
Publicado: (2021)

Immunogenic cell death-related long noncoding RNA influences immunotherapy against lung adenocarcinoma
por: SUN, DONGJIE, et al.
Publicado: (2023)

The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Identification of a Novel Prognostic Signature of Genome Instability-Related LncRNAs in Early Stage Lung Adenocarcinoma
por: Peng, Bo, et al.
Publicado: (2021)

Immunogenic cell death-associated biomarkers classification predicts prognosis and immunotherapy efficacy in pancreatic ductal adenocarcinoma
por: Peng, Wenguang, et al.
Publicado: (2023)

Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023)

Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients
por: Xu, Jun, et al.
Publicado: (2023)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
por: Cui, Yingshu, et al.
Publicado: (2023)

Identification and validation of immunogenic cell death-related score in uveal melanoma to improve prediction of prognosis and response to immunotherapy
por: Li, Xiaoyan, et al.
Publicado: (2023)

Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano-del Valle, Alfonso, et al.
Publicado: (2019)

Nanotechnology-Assisted Immunogenic Cell Death for Effective Cancer Immunotherapy
por: Guo, Yichen, et al.
Publicado: (2023)

The prognostic value and response to immunotherapy of immunogenic cell death-associated genes in breast cancer
por: Zhao, Rongling, et al.
Publicado: (2023)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
por: Dong, Bingqi, et al.
Publicado: (2023)

Identification of a prognostic index system and tumor immune infiltration characterization for lung adenocarcinoma based on mRNA molecular of pyroptosis
por: Li, Huawei, et al.
Publicado: (2022)

Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Maes, Ken, et al.
Publicado: (2019)

Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy
por: Palanivelu, Lalitha, et al.
Publicado: (2023)

Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma
por: Zong, Yuan, et al.
Publicado: (2023)

Combining immune checkpoint blockade with ATP-based immunogenic cell death amplifier for cancer chemo-immunotherapy
por: Zhang, Jiulong, et al.
Publicado: (2022)

Construction of a circRNA-Related Prognostic Risk Score Model for Predicting the Immune Landscape of Lung Adenocarcinoma
por: Li, Huawei, et al.
Publicado: (2021)

The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery
por: Wang, Jun, et al.
Publicado: (2022)

Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
por: Liu, Jichang, et al.
Publicado: (2022)

Response: Commentary: Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
por: Serrano Del Valle, Alfonso, et al.
Publicado: (2019)

The role of immunogenic cell death in gastrointestinal cancer immunotherapy (Review)
por: Songjang, Worawat, et al.
Publicado: (2021)

Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy
por: Sun, Yajie, et al.
Publicado: (2021)

Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy
por: Gao, Jing, et al.
Publicado: (2020)

Prognostic value and immune landscapes of immunogenic cell death-associated lncRNAs in lung adenocarcinoma
por: Shu, Kexin, et al.
Publicado: (2023)

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
por: Li, Zhilin, et al.
Publicado: (2022)

An immunogenic cell death-related classification predicts prognosis and response to immunotherapy in kidney renal clear cell carcinoma
por: Wang, Licheng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1chuhn1eb4pvfa1t9bichiomer